Developer docs
API playgroundTry for free, no card

Search company profiles

4DX

Full company profile

uuid0003p7h

Namestring
4DX
Legal namestring
4DMedical
Websiteurl
4dx.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

4DMedical is a Melbourne-headquartered medical technology company that develops software products for functional lung imaging and analysis based on its proprietary XV Technology platform. The company's core offering enables clinicians to extract quantitative lung function information — including ventilation, perfusion, density, volume, and texture metrics — from standard X-ray and CT scans without requiring contrast injections or specialized imaging procedures. Its product suite includes CT:VQ (FDA-cleared non-contrast ventilation-perfusion analysis), CAC (coronary artery calcification), CT LVAS, IQ-UIP (early idiopathic pulmonary fibrosis detection), LDAf, LDAi, LTA, PHA, and XV LVAS, alongside Companion Imaging software and the XV Scanner research hardware. Software is sold via quote-based enterprise subscription licensing to hospitals, health systems, radiology departments, and clinical research institutions, with notable strategic positioning around VA hospitals under the US PACT Act for veterans with toxic-exposure-related respiratory conditions.

The company generates revenue primarily through enterprise site licensing of its FDA-cleared medical imaging software, sold via a direct enterprise field-sales motion targeting healthcare providers, pulmonologists, and radiology departments, with quote-based annual or multi-year contracts typical of medical device software. Distribution occurs through direct clinical sales representatives, augmented by industry conference presence (SIIM, Florida Radiological Society) and a marketing partnership with Philips (co-exhibiting at SIIM). Customer segments are organized vertically across healthcare providers and hospital systems (primary), veterans healthcare via the VA (secondary), and clinical research institutions (tertiary). The company's strategic posture includes geographic expansion — operating from Australia, opening a US office in Woodland Hills, California, and announcing a June 2026 agreement to acquire Austrian-based contextflow for European market entry — alongside a growing regulatory footprint marked by FDA clearance for CT:VQ.

The business is early-stage in commercial scale, with cumulative disclosed funding of approximately A$15.7M across three rounds in 2018-2019 (most recent a ~A$10.1M round from Regal Funds Management), 11-50 employees, and no publicly disclosed revenue figures. Leadership includes founder and Chairman Andreas Fouras. Operational signals — product portfolio breadth, multi-region footprint, government channel positioning, and active M&A — point to a company in the scaling phase of commercialization rather than mature revenue ramp.

Short descriptiontext

4DMedical develops FDA-cleared software that extracts quantitative functional lung imaging data (ventilation, perfusion, density, volume) from standard X-ray and CT scans, licensing it via enterprise subscriptions to hospitals, VA healthcare systems, and clinical research institutions globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersCarlton, Australia
HQ citystring
Carlton
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
lung function imaging, medical imaging software, respiratory diagnostics, ventilation perfusion analysis, lung disease detection
Industry1 code
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code1 code
  • Surgical and Medical Instrument Manufacturing339112
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Imaging Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Imaging Software Licensing
TypeSubscription Recurring
Description

4DMedical generates revenue through licensing its FDA-cleared lung function imaging analysis software to healthcare providers, hospitals, and clinical research institutions. Software is sold as clinical diagnostic tools with enterprise licensing arrangements typical of medical device software.

4dmedical.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
Pricing details1 tier
1Enterprise site licensing for healthcare institutions
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing; annual or multi-year contracts typical for medical software licensing to health systems

4dmedical.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

4DMedical develops and licenses FDA-cleared medical imaging software that quantifies lung function from standard X-ray and CT scans using its proprietary XV Technology platform. The product portfolio includes CT:VQ (non-contrast ventilation-perfusion analysis), CAC (coronary artery calcification), CT LVAS, XV LVAS, IQ-UIP (early IPF detection), LDAf, LDAi, LTA, PHA, and Companion Imaging. The company also offers the XV Scanner hardware for clinical research applications and licenses its software to hospitals, radiology departments, and VA health systems.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Enables diagnosis of breathing conditions from standard X-ray scans without additional imaging procedures
Product overview1 text field

4DMedical is a medical imaging software company offering a portfolio of specialized lung function imaging and analysis products. The core offering is built on the proprietary XV Technology platform, which enables breakthrough functional lung imaging from standard X-ray and CT scans. The product suite includes CT:VQ (non-contrast ventilation-perfusion analysis, FDA-cleared), CAC (coronary artery calcification), CT LVAS (CT lung volume analysis), IQ-UIP (early IPF detection), LDAf (functional lung density analysis), LDAi (lung density analysis inspiration), LTA (lung texture analysis), PHA (pulmonary hypertension assessment), XV LVAS (lung ventilation analysis), and Companion Imaging. The company also offers the XV Scanner for lung function research. In June 2026, the company announced an agreement to acquire European software lung imaging leader contextflow for European market expansion.

Product and service11 records
1CT:VQ™
CategoryMedical Imaging Software
Description

Non-contrast ventilation-perfusion imaging and analysis software that is FDA-cleared for assessing lung function without injections, used by hospitals and radiology departments for comprehensive lung function assessment.

2CAC™
CategoryMedical Imaging Software
Description

Coronary Artery Calcification detection and analysis software for healthcare providers performing cardiovascular assessments.

3CT LVAS™
CategoryMedical Imaging Software
Description

CT Lung Volume Analysis software for quantitative lung ventilation analysis from standard CT scans.

4IQ-UIP™
CategoryMedical Imaging Software
Description

Early Idiopathic Pulmonary Fibrosis (IPF) detection software for healthcare providers identifying early-stage IPF from standard imaging.

5LDAf™
CategoryMedical Imaging Software
Description

Functional Lung Density Analysis software for assessing functional lung density from standard imaging scans.

6LDAi™
CategoryMedical Imaging Software
Description

Lung Density Analysis – Inspiration software for analyzing lung density during inspiration from standard imaging scans.

7LTA™
CategoryMedical Imaging Software
Description

Lung Texture Analysis software for assessing lung tissue characteristics and patterns from standard imaging.

8PHA™
CategoryMedical Imaging Software
Description

Pulmonary Hypertension Assessment software for evaluating pulmonary hypertension from lung function imaging.

9XV LVAS®
CategoryMedical Imaging Software
Description

XV Lung Volume Analysis software for lung ventilation analysis using the proprietary XV Technology platform.

10Companion Imaging
CategoryMedical Imaging Software
Description

Supporting imaging software module for comprehensive lung analysis alongside other 4DMedical software products.

11XV Scanner™
CategoryMedical Imaging Hardware
Description

Lung function research scanner hardware for clinical research applications, used by academic medical centers and research institutions conducting lung function research.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-01
Description

4DMedical announced agreement to acquire contextflow, a European software lung imaging leader, marking the company's expansion into the European market. This acquisition is intended to strengthen 4DMedical's presence in Europe and expand its product capabilities in lung imaging software.

Strategic tierMinorTypeGTM or Marketing Partner
Description

4DMedical exhibits at the Philips booth at SIIM conference, indicating a marketing and channel partnership for joint market presence in the medical imaging space. Philips is a major medical imaging equipment vendor with extensive hospital relationships.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Under the PACT Act, 4DMedical's software enables VA hospitals to diagnose and treat millions of veterans with breathing conditions related to toxic exposure and airborne hazards during military service.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Philips is a global medical imaging equipment and PACS vendor with which 4DMedical has a marketing partnership at SIIM. Philips is a broad incumbent that could bundle competing lung imaging analytics into its installed base, and a channel partner for 4DMedical's enterprise reach.

TypeDirect peer
Description

Optellum develops AI software for early lung cancer diagnosis and management using CT imaging, with FDA-cleared Virtual Nodule Clinic. It is a direct peer to 4DMedical within the lung imaging AI category, addressing similar pulmonology and radiology workflows.

TypeDirect peer
Description

VIDA Diagnostics provides AI-powered lung image analysis software (including LungPrint) for pulmonary conditions such as COPD and emphysema. It is the closest direct peer to 4DMedical, serving the same pulmonology and radiology customer base with quantitative lung analytics from CT scans.

TypeDirect peer
Description

HeartFlow offers SaaS-based AI analysis (FFR-CT) for coronary imaging from standard CT scans, sold via enterprise licensing to hospitals. It is a strong functional peer: same SaaS-to-enterprise-healthcare model, same workflow of converting standard scans into higher-value diagnostic outputs.

TypeDirect peer
Description

Thirona specializes in AI-based medical image analysis for lung and chest CT, with products such as LungQ for quantitative lung analysis. It is a direct peer in lung-focused imaging analytics and serves academic and clinical research customers similar to 4DMedical's research segment.

TypeEmerging player
Description

Arterys (now part of Tempus) provides cloud-native AI imaging analytics for cardiac and other imaging, with enterprise hospital SaaS distribution. It is comparable to 4DMedical in imaging AI SaaS go-to-market and clinical decision-support positioning.

TypeEmerging player
Description

Viz.ai delivers AI-driven imaging workflow software (notably stroke and cardiology) to hospital systems. Comparable to 4DMedical as a clinical AI imaging platform sold to enterprise health systems, though focused on time-sensitive vascular indications rather than lung.

TypeEmerging player
Description

Aidoc is an AI radiology platform offering triage and workflow AI across multiple imaging modalities to health systems. It overlaps with 4DMedical in AI-driven radiology analytics and enterprise hospital sales, though Aidoc spans organs rather than specializing in lung.

TypeBroad incumbent
Description

GE HealthCare is a major imaging equipment and PACS/AW vendor serving hospitals globally. It is comparable as a broad incumbent that dominates hospital radiology workflows and could develop or acquire competing AI lung analytics features.

TypeDirect peer
Description

contextflow is a European AI lung imaging software company that 4DMedical has agreed to acquire. It is a direct peer in AI-powered lung image analysis and represents 4DMedical's European counterpart before consolidation.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

4DX

Medical Imaging Software4dx.com

4DMedical develops FDA-cleared software that extracts quantitative functional lung imaging data (ventilation, perfusion, density, volume) from standard X-ray and CT scans, licensing it via enterprise subscriptions to hospitals, VA healthcare systems, and clinical research institutions globally.

What 4DX does

4DMedical is a Melbourne-headquartered medical technology company that develops software products for functional lung imaging and analysis based on its proprietary XV Technology platform. The company's core offering enables clinicians to extract quantitative lung function information — including ventilation, perfusion, density, volume, and texture metrics — from standard X-ray and CT scans without requiring contrast injections or specialized imaging procedures. Its product suite includes CT:VQ (FDA-cleared non-contrast ventilation-perfusion analysis), CAC (coronary artery calcification), CT LVAS, IQ-UIP (early idiopathic pulmonary fibrosis detection), LDAf, LDAi, LTA, PHA, and XV LVAS, alongside Companion Imaging software and the XV Scanner research hardware. Software is sold via quote-based enterprise subscription licensing to hospitals, health systems, radiology departments, and clinical research institutions, with notable strategic positioning around VA hospitals under the US PACT Act for veterans with toxic-exposure-related respiratory conditions.

The company generates revenue primarily through enterprise site licensing of its FDA-cleared medical imaging software, sold via a direct enterprise field-sales motion targeting healthcare providers, pulmonologists, and radiology departments, with quote-based annual or multi-year contracts typical of medical device software. Distribution occurs through direct clinical sales representatives, augmented by industry conference presence (SIIM, Florida Radiological Society) and a marketing partnership with Philips (co-exhibiting at SIIM). Customer segments are organized vertically across healthcare providers and hospital systems (primary), veterans healthcare via the VA (secondary), and clinical research institutions (tertiary). The company's strategic posture includes geographic expansion — operating from Australia, opening a US office in Woodland Hills, California, and announcing a June 2026 agreement to acquire Austrian-based contextflow for European market entry — alongside a growing regulatory footprint marked by FDA clearance for CT:VQ.

The business is early-stage in commercial scale, with cumulative disclosed funding of approximately A$15.7M across three rounds in 2018-2019 (most recent a ~A$10.1M round from Regal Funds Management), 11-50 employees, and no publicly disclosed revenue figures. Leadership includes founder and Chairman Andreas Fouras. Operational signals — product portfolio breadth, multi-region footprint, government channel positioning, and active M&A — point to a company in the scaling phase of commercialization rather than mature revenue ramp.

4DX firmographics

Firmographics
Name
4DX
Legal name
4DMedical
Website
https://4dx.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
101–250 employees
Short description
4DMedical develops FDA-cleared software that extracts quantitative functional lung imaging data (ventilation, perfusion, density, volume) from standard X-ray and CT scans, licensing it via enterprise subscriptions to hospitals, VA healthcare systems, and clinical research institutions globally.
Ownership category
akta.pro rank

4DX industry classification

Industry
Product category
Medical Imaging Software
NAICS
Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Lung function imaging
  • Medical imaging software
  • Respiratory diagnostics
  • Ventilation perfusion analysis
  • Lung disease detection

Where 4DX is headquartered

Location

Headquarters

HQ city
Carlton
HQ country
Australia
HQ region
Oceania

Offices2 records

Markets served

4DX business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Medical Imaging Software Licensing: 4DMedical generates revenue through licensing its FDA-cleared lung function imaging analysis software to healthcare providers, hospitals, and clinical research institutions. Software is sold as clinical diagnostic tools with enterprise licensing arrangements typical of medical device software.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise site licensing for healthcare institutions

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

4DX product offering

Product offering

Core offering

4DMedical develops and licenses FDA-cleared medical imaging software that quantifies lung function from standard X-ray and CT scans using its proprietary XV Technology platform. The product portfolio includes CT:VQ (non-contrast ventilation-perfusion analysis), CAC (coronary artery calcification), CT LVAS, XV LVAS, IQ-UIP (early IPF detection), LDAf, LDAi, LTA, PHA, and Companion Imaging. The company also offers the XV Scanner hardware for clinical research applications and licenses its software to hospitals, radiology departments, and VA health systems.

Product overview

4DMedical is a medical imaging software company offering a portfolio of specialized lung function imaging and analysis products. The core offering is built on the proprietary XV Technology platform, which enables breakthrough functional lung imaging from standard X-ray and CT scans. The product suite includes CT:VQ (non-contrast ventilation-perfusion analysis, FDA-cleared), CAC (coronary artery calcification), CT LVAS (CT lung volume analysis), IQ-UIP (early IPF detection), LDAf (functional lung density analysis), LDAi (lung density analysis inspiration), LTA (lung texture analysis), PHA (pulmonary hypertension assessment), XV LVAS (lung ventilation analysis), and Companion Imaging. The company also offers the XV Scanner for lung function research. In June 2026, the company announced an agreement to acquire European software lung imaging leader contextflow for European market expansion.

Differentiator

Problem solved

Functional benefit

Products and services

  • CT:VQ™ Non-contrast ventilation-perfusion imaging and analysis software that is FDA-cleared for assessing lung function without injections, used by hospitals and radiology departments for comprehensive lung function assessment.
  • CAC™ Coronary Artery Calcification detection and analysis software for healthcare providers performing cardiovascular assessments.
  • CT LVAS™ CT Lung Volume Analysis software for quantitative lung ventilation analysis from standard CT scans.
  • IQ-UIP™ Early Idiopathic Pulmonary Fibrosis (IPF) detection software for healthcare providers identifying early-stage IPF from standard imaging.
  • LDAf™ Functional Lung Density Analysis software for assessing functional lung density from standard imaging scans.
  • LDAi™ Lung Density Analysis – Inspiration software for analyzing lung density during inspiration from standard imaging scans.
  • LTA™ Lung Texture Analysis software for assessing lung tissue characteristics and patterns from standard imaging.
  • PHA™ Pulmonary Hypertension Assessment software for evaluating pulmonary hypertension from lung function imaging.
  • XV LVAS® XV Lung Volume Analysis software for lung ventilation analysis using the proprietary XV Technology platform.
  • Companion Imaging Supporting imaging software module for comprehensive lung analysis alongside other 4DMedical software products.
  • XV Scanner™ Lung function research scanner hardware for clinical research applications, used by academic medical centers and research institutions conducting lung function research.

Quantifiable outcome

  • Enables diagnosis of breathing conditions from standard X-ray scans without additional imaging procedures

Companies that use 4DX

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

4DX technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

4DX partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • contextflowcoreStrategic or Co-development Partner · 1 June 20264DMedical announced agreement to acquire contextflow, a European software lung imaging leader, marking the company's expansion into the European market. This acquisition is intended to strengthen 4DMedical's presence in Europe and expand its product capabilities in lung imaging software.
  • PhilipsminorGTM or Marketing Partner4DMedical exhibits at the Philips booth at SIIM conference, indicating a marketing and channel partnership for joint market presence in the medical imaging space. Philips is a major medical imaging equipment vendor with extensive hospital relationships.
  • VA (Veterans Affairs)coreStrategic or Co-development PartnerUnder the PACT Act, 4DMedical's software enables VA hospitals to diagnose and treat millions of veterans with breathing conditions related to toxic exposure and airborne hazards during military service.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

4DX competitors and assessment

Company assessment

Broad incumbents

  • Philips: Philips is a global medical imaging equipment and PACS vendor with which 4DMedical has a marketing partnership at SIIM. Philips is a broad incumbent that could bundle competing lung imaging analytics into its installed base, and a channel partner for 4DMedical's enterprise reach.
  • GE HealthCare: GE HealthCare is a major imaging equipment and PACS/AW vendor serving hospitals globally. It is comparable as a broad incumbent that dominates hospital radiology workflows and could develop or acquire competing AI lung analytics features.

Direct peers

  • Optellum: Optellum develops AI software for early lung cancer diagnosis and management using CT imaging, with FDA-cleared Virtual Nodule Clinic. It is a direct peer to 4DMedical within the lung imaging AI category, addressing similar pulmonology and radiology workflows.
  • VIDA Diagnostics: VIDA Diagnostics provides AI-powered lung image analysis software (including LungPrint) for pulmonary conditions such as COPD and emphysema. It is the closest direct peer to 4DMedical, serving the same pulmonology and radiology customer base with quantitative lung analytics from CT scans.
  • HeartFlow: HeartFlow offers SaaS-based AI analysis (FFR-CT) for coronary imaging from standard CT scans, sold via enterprise licensing to hospitals. It is a strong functional peer: same SaaS-to-enterprise-healthcare model, same workflow of converting standard scans into higher-value diagnostic outputs.
  • Thirona: Thirona specializes in AI-based medical image analysis for lung and chest CT, with products such as LungQ for quantitative lung analysis. It is a direct peer in lung-focused imaging analytics and serves academic and clinical research customers similar to 4DMedical's research segment.
  • contextflow: contextflow is a European AI lung imaging software company that 4DMedical has agreed to acquire. It is a direct peer in AI-powered lung image analysis and represents 4DMedical's European counterpart before consolidation.

Emerging players

  • Arterys: Arterys (now part of Tempus) provides cloud-native AI imaging analytics for cardiac and other imaging, with enterprise hospital SaaS distribution. It is comparable to 4DMedical in imaging AI SaaS go-to-market and clinical decision-support positioning.
  • Viz.ai: Viz.ai delivers AI-driven imaging workflow software (notably stroke and cardiology) to hospital systems. Comparable to 4DMedical as a clinical AI imaging platform sold to enterprise health systems, though focused on time-sensitive vascular indications rather than lung.
  • Aidoc: Aidoc is an AI radiology platform offering triage and workflow AI across multiple imaging modalities to health systems. It overlaps with 4DMedical in AI-driven radiology analytics and enterprise hospital sales, though Aidoc spans organs rather than specializing in lung.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

4DX social profiles

Digital presence

4DX financial estimates

Financial estimate

Revenue estimate

Valuation estimate

4DX leadership team

Management profile

Number of profiles

Profiles1 record

4DX subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

4DX funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

4DX M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 4DX

What does 4DX do?

4DMedical develops and licenses FDA-cleared medical imaging software that quantifies lung function from standard X-ray and CT scans using its proprietary XV Technology platform. The product portfolio includes CT:VQ (non-contrast ventilation-perfusion analysis), CAC (coronary artery calcification), CT LVAS, XV LVAS, IQ-UIP (early IPF detection), LDAf, LDAi, LTA, PHA, and Companion Imaging. The company also offers the XV Scanner hardware for clinical research applications and licenses its software to hospitals, radiology departments, and VA health systems.

When was 4DX founded?

4DX was founded in 2012. It employs 101 to 250 people.

Where is 4DX based?

4DX is headquartered in Carlton, Australia, in the Oceania region.

How does 4DX make money?

One revenue line is on record: medical Imaging Software Licensing.

Who are 4DX's main competitors?

Broad incumbents on record are Philips and GE HealthCare. Direct peers are Optellum, VIDA Diagnostics, HeartFlow, Thirona and contextflow. Emerging players are Arterys, Viz.ai and Aidoc.

Does 4DX have an API?

No public API is recorded for 4DX.

What industry is 4DX in?

4DX's product category is Medical Imaging Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Australian Financial ReviewAnother client fires EL&C Baillieu amid scandal4Dx hired Bell Potter and Evans & Partners to float the medical-tech company, after EL&C Baillieu lost the client. The decision follows a corporate sting that damaged EL&C Baillieu, which is mostly owned by Credit Suisse and its senior staff.Illawarra MercuryNew Aust technology to treat lung diseaseMonash University researchers developed a non-invasive X-ray technology to image airflow through lungs in real time, improving diagnosis and treatment of lung diseases. The technology, commercialized by 4Dx Limited, aims to help cystic fibrosis patients and other respiratory conditions.PR Newswire4DX and ScreenX Unveil New Logo As Part Of Its New BrandingCJ 4DPLEX unveiled new logos for its cinema technology brands 4DX and ScreenX as part of a global rebranding effort, designed by Interbrand to increase brand consistency across markets. The new branding aims to position 4DX as an exciting cinematic experience for the next decade as the company marks its 10th anniversary, with 4DX having reached 110 million cumulative global audiences. The rebranding includes renaming '4DX with ScreenX' auditoriums to '4DX Screen,' which currently operates in 22 locations worldwide.PR Newswire4Dx Announces Preliminary Clinical Trial Data at Prestigious World Lung Imaging Event4Dx presented preliminary clinical study data at the World Lung Imaging Workshop held at the University of Pennsylvania on March 9, 2017, with CEO Dr. Andreas Fouras delivering the results to pulmonary medicine leaders. The technology, which captures 4D imaging of lung airflow function at high resolution, was validated by researchers at Cedars-Sinai's Biomedical Imaging Research Institute, where the study is being conducted. The company positions itself within a $30 billion per annum respiratory diagnostics addressable market and expects increased interest from clinical groups and investors following this milestone.PR NewswireAustralia's 4Dx Making Waves in U.S. HealthcareAustralian medtech startup 4Dx is expanding into the U.S. healthcare market by securing partnerships with major hospitals and appointing Dr. Bob Figlin to its Board of Directors. The company is currently raising capital through a Series A round to fund this expansion and support clinical trials leading to anticipated FDA approval next year.